Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.

Gajanan SatheChan Hyun NaSantosh RenuseAnil K MadugunduMarilyn AlbertAbhay MoghekarAkhilesh Pandey

Published in: Proteomics. Clinical applications (2019)

The proteins that are found to be altered in the CSF of patients with AD could be used for monitoring disease progression and therapeutic response and perhaps also for early detection once they are validated in larger studies.

Keyphrases

cerebrospinal fluid
cognitive decline
high resolution
single cell
label free